Education
About Us
Working with TipRanks
Follow Us
Alpha Tau Medical Ltd (DRTS)
NASDAQ:DRTS
DRTS Stock Chart & Stats
$4.21
$0.35(10.45%)
At close: 4:00 PM EST
$4.21
$0.35(10.45%)
Day’s Range― - ―
52-Week Range$2.14 - $4.69
Previous CloseN/A
Volume116.73K
Average Volume (3M)63.07K
Market Cap
$355.74M
Enterprise Value$180.76M
Total Cash (Recent Filing)$79.70M
Total Debt (Recent Filing)$13.31M
Price to Earnings (P/E)―
Beta0.63
Next Earnings
Nov 25, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding84,699,720
10 Day Avg. Volume70,102
30 Day Avg. Volume63,069
Financial Highlights & Ratios
PEG Ratio-0.96
Price to Book (P/B)3.46
Price to Sales (P/S)0.00
P/FCF Ratio-9.84
Enterprise Value/Market Cap0.51
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-5.62
Forecast
1Y Price Target
$8.50Price Target Upside101.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
Analyst RecommendationThe analyst's recommendation for Alpha Tau Medical Ltd is Buy / High Risk with a significant expected share price return.
Clinical TrialsAlpha Tau Medical announced that the first patient has been treated in the U.S. pilot study of Alpha DaRT in patients with pancreatic cancer.
Regulatory ApprovalAlpha Tau Medical announced that it has secured a radioactive material license from the New Hampshire Bureau of Public Health Protection, Radiological Health Section, following completion of the first phase of construction of its commercial scale manufacturing facility in Hudson, NH.
Bears Say
Financial PerformanceNet loss was $10.1M, or ($0.13) per share, moderately higher than the estimated loss of $9.3M.
Alpha Tau Medical Ltd News
DRTS FAQ
What was Alpha Tau Medical Ltd’s price range in the past 12 months?
Alpha Tau Medical Ltd lowest stock price was $2.14 and its highest was $4.69 in the past 12 months.
What is Alpha Tau Medical Ltd’s market cap?
Alpha Tau Medical Ltd’s market cap is $355.74M.
When is Alpha Tau Medical Ltd’s upcoming earnings report date?
Alpha Tau Medical Ltd’s upcoming earnings report date is Nov 25, 2025 which is in 31 days.
How were Alpha Tau Medical Ltd’s earnings last quarter?
Alpha Tau Medical Ltd released its earnings results on Aug 11, 2025. The company reported -$0.13 earnings per share for the quarter, missing the consensus estimate of -$0.111 by -$0.019.
Is Alpha Tau Medical Ltd overvalued?
According to Wall Street analysts Alpha Tau Medical Ltd’s price is currently Undervalued.
Does Alpha Tau Medical Ltd pay dividends?
Alpha Tau Medical Ltd does not currently pay dividends.
What is Alpha Tau Medical Ltd’s EPS estimate?
Alpha Tau Medical Ltd’s EPS estimate is -0.12.
How many shares outstanding does Alpha Tau Medical Ltd have?
Alpha Tau Medical Ltd has 84,699,720 shares outstanding.
What happened to Alpha Tau Medical Ltd’s price movement after its last earnings report?
Alpha Tau Medical Ltd reported an EPS of -$0.13 in its last earnings report, missing expectations of -$0.111. Following the earnings report the stock price went down -8.708%.
Which hedge fund is a major shareholder of Alpha Tau Medical Ltd?
Currently, no hedge funds are holding shares in DRTS
Alpha Tau Medical Ltd Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.50 (101.90% Upside)
$8.50 (101.90% Upside)
Blogger Sentiment
Bullish
DRTS Sentiment 100%
Sector Average 68%
Sector Average 68%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
82.80%
12-Months-Change
Fundamentals
Return on Equity
-43.83%
Trailing 12-Months
Asset Growth
15.52%
Trailing 12-Months
Company Description
Alpha Tau Medical Ltd
Alpha Tau Medical Ltd (DRTS) is a medical technology company focused on the research, development, and commercialization of innovative cancer treatment solutions. The company specializes in the development of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), a breakthrough approach to cancer therapy that harnesses the power of alpha-emitting isotopes to selectively destroy cancerous tumors while minimizing damage to surrounding healthy tissue. Alpha Tau Medical operates within the biotechnology and healthcare sectors, striving to advance cancer treatment options and improve patient outcomes.
DRTS Stock 12 Month Forecast
Average Price Target
$8.50
▲(101.90% Upside)
Technical Analysis
Larimar Therapeutics
―
Capricor Therapeutics
―
Benitec Biopharma
―
Aura Biosciences Inc
―
Lexeo Therapeutics, Inc.
―
Ownership Overview
―
Insiders
0.04% Mutual Funds
<0.01% Other Institutional Investors
99.95% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---